Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UCB Major Shareholding Notification 2017

Feb 16, 2017

4017_mrq_2017-02-16_4d213925-dbea-48b5-8dc0-65886be358fc.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Brussels (Belgium), 16 February 2017 – 20:00 (CET) – regulated information

1. Summary of the notification

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification dated 13 February 2017, from BlackRock, Inc. (having its registered offices at 55 East 52nd Street, New York, NY, 10055, U.S.A.).

BlackRock, Inc. has notified that, following an acquisition of UCB shares with voting rights by its affiliates, its shareholding in UCB SA/NV has increased and has crossed the 3% threshold on 10 February 2017.

On 10 February 2017, BlackRock, Inc. (taking into account the holding of its affiliates) owned 5 994 140 UCB shares with voting rights (versus 5 776 620 shares in its previous notification dated 3 February 2017), representing 3.08% of the total number of shares issued by the company (194 505 658) (versus 2.97% in the notification dated 3 February 2017).

2. Content of the notification

The transparency notification dated 13 February 2017 includes the following information:

  • Reason for the notification: Acquisition or disposal of voting securities or voting rights
  • Notification by: A parent undertaking or a controlling person.
  • Persons subject to the notification requirement:
Name Address (for legal entities)
BlackRock, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock (Netherlands) B.V. Rembrandt Tower, 17th floor, Amstelplein, Amsterdam, Netherlands
BlackRock (Singapore) Limited 20 Anson Road #18-01, Singapore, 79912, Singapore
BlackRock Advisors (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Advisors, LLC 100 Bellevue Parkway, Wilmington, DE, 19809, U.S.A.
BlackRock Asset Management Canada Limited 161 Bay Street, Suite 2500, Toronto, Ontario, M5J 2S1, Canada
BlackRock Asset Management Deutschland AG Max-Joseph-Straße 6, Munich, 80333, Germany
BlackRock Asset Management North Asia Limited 15/F, 16/F, 17/F Citibank Tower & 17/F ICBC Tower, 3 Garden Road, Central,
Hong Kong
BlackRock Financial Management, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock Fund Advisors 400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock Institutional Trust Company, National
Association
400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock International Limited Exchange Place One, 1 Semple Street, Edinburgh, EH3 8BL, U.K.
BlackRock Investment Management (Australia)
Limited
Level 37, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 Australia
BlackRock Investment Management (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Investment Management, LLC 1 University Square Drive, Princeton, NJ, 8540, U.S.A.
BlackRock Japan Co., Ltd. 1-8-3 Marunouchi Chiyoda-ku, Trust Tower Main, Tokyo, 100-8217, Japan
  • Date on which the threshold is crossed: 10 February 2017.
  • Threshold crossed (in %): 3%.
  • Denominator: 194 505 658.
  • Notified details:

UCB
News

A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the
securities
Linked to
securities
Not linked to the
securities
BlackRock, Inc. $\Omega$ $\Omega$ 0.00%
BlackRock (Netherlands) B.V. 19.816 19.816 0.01%
BlackRock (Singapore) Limited 6.386 6.386 0,00%
BlackRock Advisors (UK) Limited 859.423 958.312 0.49%
BlackRock Advisors, LLC 63.253 62.718 0,03%
BlackRock Asset Management
Canada Limited
61.391 61.391 0,03%
BlackRock Asset Management
Deutschland AG
230,309 230.309 0,12%
BlackRock Asset Management North
Asia Limited
644 644 0,00%
BlackRock Financial Management,
Inc.
92.346 78.139 0,04%
BlackRock Fund Advisors 1.794.760 1.800.382 0,93%
BlackRock Institutional Trust
Company, National Association
2.033.398 1.996.341 1,03%
BlackRock International Limited 11.609 11.609 0,01%
BlackRock Investment Management
(Australia) Limited
41.852 41.852 0,02%
BlackRock Investment Management
(UK) Limited
151.778 153.176 0,08%
BlackRock Investment Management,
LLC
230.604 230.744 0,12%
BlackRock Japan Co., Ltd. 179.051 342.321 0,18%
Subtotal 5.776.620 5.994.140 3,08%
TOTAL 5.994.140 $\mathbf 0$ 3,08% 0,00%
B) Equivalent financial instruments After the transaction
Holders of equivalent
financial instruments
Type of financial instrument Exercise period or
Expiration date
date
# of voting rights
that may be
acquired if the
instrument is
exercised
% of voting rights Settlement
financial instruments Type of financial instrument Expiration date date acquired if the
instrument is
exercised
% of voting rights Settlement
BlackRock Advisors (UK) Limited Securities Lent 144.934 0,07% physical
BlackRock Advisors, LLC Securities Lent 751 0,00% physical
BlackRock Fund Advisors Securities Lent 910 0,00% physical
BlackRock Institutional Trust
Company, National Association
Securities Lent 20.684 0,01% physical
BlackRock Investment Management
(UK) Limited
Securities Lent 9.956 0,01% physical
BlackRock Japan Co., Ltd. Securities Lent 14.677 0,01% physical
BlackRock Institutional Trust
Company, National Association
Contract for Difference 7.683 0,00% cash
TOTAL 199.595 0,10%
TOTAL (A & B) # of voting rights % of voting rights
CALCULATE 6.193.735 3,18%

Chain of controlled undertakings through which the holding is effectively held:

Please see the full chain of control in the PDF which is attached to the notification.

Additional information:

The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going above 3%.

3. Further information

This press release and the detailed transparency notification is available on UCB SA/NV's website via the following link.

An updated overview of the UCB SA/NV large shareholdings will be available on UCB SA/NV's website via the following link.

Investor Relations

Antje Witte, Investor Relations, UCB T +32 2 559 94 14, [email protected]

Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, [email protected]

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people in approximately 40 countries, the company generated revenue of € 3.9 billion in 2015. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news